High-throughput mutagenesis reveals unique structural features of human ADAR1

Area of Science:

• Molecular Biology
• Structural Biology
• Biochemistry

Background:

• Adenosine Deaminases that act on RNA (ADARs) are key enzymes in RNA editing, converting adenosine to inosine in double-stranded RNA (dsRNA).
• The human ADAR1 gene is implicated in various diseases, and ADAR1 is emerging as a therapeutic target for certain cancers.
• A lack of structural information has hindered understanding of ADAR1's disease mechanisms and the development of inhibitors.

Purpose of the Study:

• To elucidate unique structural features of ADAR1 using integrated computational and experimental approaches.
• To identify novel structural elements critical for ADAR1's enzymatic activity.
• To provide a structural basis for understanding ADAR1-associated diseases and guide inhibitor design.

Main Methods:

• High-throughput mutagenesis screening of ADAR1.
• Biochemical characterization of ADAR1 variants.
• Rosetta-based computational structure modeling.

Main Results:

• Identification of a previously unrecognized zinc-binding site on the ADAR1 deaminase domain.
• Demonstration that this zinc-binding site is essential for ADAR1's RNA editing function.
• Development of structural models explaining known ADAR1 properties and predicting residue functions.

Conclusions:

• The newly discovered zinc-binding site is a critical determinant of ADAR1 enzymatic activity.
• Structural insights gained can inform the development of targeted therapies for ADAR1-related diseases and cancers.
• Further investigation into ADAR1's unique surface loop may reveal additional functional mechanisms.